Sign in

You're signed outSign in or to get full access.

Lawrence Sharnak

Director at CareCloud
Board

About Lawrence S. Sharnak

Independent director at CareCloud, Inc. (CCLD) since April 2020; age 71. Sharnak spent 30+ years at American Express in senior leadership roles and founded several employee networks (Asian Network; Professional Orientation and Development Program; Consumer Card Diversity Team). He holds a BBA from the University of Massachusetts and an MBA from Babson College. He is independent under Nasdaq rules and currently serves on the Audit Committee, the Nominating & Corporate Governance Committee, and chairs the Cybersecurity Subcommittee. He is nominated for re‑election at the May 27, 2025 Annual Meeting .

Past Roles

OrganizationRoleTenureCommittees/Impact
American ExpressSenior leadership roles (multiple)30+ yearsFounding sponsor of multiple employee networks (Asian Network; Professional Orientation and Development Program; Consumer Card Diversity Team)

External Roles

OrganizationRoleTenureNotes
Cinch Board ServicesBoard of AdvisorsNot disclosedCurrent advisory role
Teach for America New JerseyDirector (prior)Not disclosedFormer board seat
A+ for KidsDirector (prior)Not disclosedFormer board seat
Consultants to GoDirector (prior)Not disclosedFormer board seat
Boca GroveDirector (prior)Not disclosedFormer board seat

Board Governance

ItemDetailEvidence
IndependenceDetermined independent by Board under Nasdaq rules
Committees (2024)Audit (member); Nominating & Corporate Governance (member); Cybersecurity Subcommittee (Chair)
Audit Committee compositionAnne M. Busquet (Chair), Lawrence S. Sharnak, John N. Daly
Meetings held in 2024Board: 5; Audit: 5; Compensation: 4; Governance: 4; Cybersecurity: 4
AttendanceEach director attended at least 75% of Board and applicable committee/subcommittee meetings in 2024
Board size7 directors
LeadershipExecutive Chairman; Co-CEOs effective Jan 1, 2025
2025 statusNominee for re‑election at May 27, 2025 meeting

Fixed Compensation

YearCash Retainer (Fees Earned)Committee Chair FeesMeeting FeesNotes
2024$48,000 N/A for Sharnak (Audit chair add'l retainer applies only to chair) None (no per‑meeting fees) Non‑employee directors receive a monthly retainer plus RSUs

Performance Compensation

ComponentDetail2024/Status
Stock awards vested (director equity)Value recognized in 2024$40,700
RSUs outstanding (as of 12/31/2024)Unvested RSUs at year‑end45,000 units
New RSU grant (Q3 2024)30,000 RSUs to each outside director; vest 25% increments over next two years beginning Feb 2025Granted Q3 2024; excluded from 2024 table because vesting began Feb 2025
Equity program designAnnual RSUs to directors under policy; automatic initial/annual awards at director appointment and Q3 Board meetingPolicy confirms non‑employee director grants are automatic; Committee may not make discretionary grants to directors

Other Directorships & Interlocks

  • Current public company directorships: None disclosed in CareCloud’s director biography (current advisory role at Cinch Board Services only) .
  • Compensation Committee interlocks: Compensation Committee consisted of John N. Daly and Cameron P. Munter in 2024; no interlocks involving Sharnak disclosed .

Expertise & Qualifications

  • 30+ years of senior leadership at American Express; experience in large‑scale consumer finance operations and organizational leadership .
  • Committee leadership in cybersecurity as subcommittee chair; active role in audit oversight as Audit Committee member (Audit Chair/financial expert is Anne M. Busquet) .
  • Education: BBA (University of Massachusetts), MBA (Babson College) .

Equity Ownership

As ofBeneficial Ownership (Common)Percent of ClassPreferred OwnershipNotes/Policies
Mar 31, 202599,000 shares 0.2% None disclosed Hedging, short sales, and pledging prohibited (pledging only by exception with pre‑approval)

Additional compliance note: The company reported directors complied with Section 16(a) filing requirements during 2024; the only delinquency noted was for a former CFO (not a director), subsequently corrected .

Governance Assessment

  • Positives

    • Independent director with multi‑committee service (Audit; Nominating & Governance) and chair of Cybersecurity Subcommittee, aligning him with financial reporting integrity and cyber risk oversight—key investor priorities .
    • Attendance threshold met (≥75% of Board/committee meetings) and active board/committee cadence in 2024 (Board 5; Audit 5; Governance 4; Cybersecurity 4), indicating engagement .
    • Equity alignment via annual RSUs; 45,000 RSUs outstanding and additional 30,000 RSUs granted in Q3 2024 with multi‑year vesting; 2024 equity value recognized $40,700, supporting long‑term alignment .
    • Beneficial ownership of 99,000 common shares (0.2% of outstanding) enhances skin‑in‑the‑game for a small‑cap issuer .
  • Watch items / potential red flags (board‑level, not attributed to Sharnak)

    • Related‑party transactions with Executive Chairman (office leases, facility upgrades; spouse physician client revenue) present ongoing governance sensitivity; board policy requires Audit Committee review/approval .
    • 2024 consulting agreement with an entity owned by a Board member for investor relations services (later reduced) reflects a potential independence/perception issue; the filing does not attribute this arrangement to Sharnak .
    • Executive leadership structure (Executive Chairman; Co‑CEOs effective 1/1/2025) can concentrate influence; mitigated by fully independent committees, including Audit where Sharnak serves .

No related‑person transactions were identified as involving Lawrence S. Sharnak in the proxy; the company’s hedging/pledging prohibitions reduce alignment risks for directors and officers .

Director Compensation (2024 detail)

MetricValue
Cash fees$48,000
Stock awards recognized (vested)$40,700
Total$88,700

Policy notes: Non‑employee directors receive a monthly retainer plus RSUs; no meeting fees; Audit Committee chair receives an additional retainer (not applicable to Sharnak) .

Related-Party Exposure (Context)

  • RPT Policy: Audit Committee reviews/approves any “Related Person Transaction” over $54,500; policy in place and written .
  • 2024 RPTs highlighted: related‑party leases and facility upgrades with Executive Chairman; revenues from physician practice of Executive Chairman’s spouse; consulting arrangements with a former non‑independent director; investor relations consulting with a director‑owned entity (unnamed). None are attributed to Sharnak in the filing .

Summary Signals for Investors

  • Strong governance contribution via Audit and Governance committees and chairing Cybersecurity; independence confirmed .
  • Alignment through equity grants and meaningful personal share ownership; hedging/pledging prohibitions in place .
  • Board‑level related‑party dealings persist (not involving Sharnak), warranting continued investor monitoring of committee oversight and disclosures .